The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Kim I.A.
N.I. Pirogov Russian National Research Medical University;
National Medical Research Center of Otorhinolaryngology of Federal Medical-Biological Agency
Nosulya E.V.
Sverzhevky Research Clinical Institute of Otorhinolaryngology
Ragimova D.R.
Pirogov National Research Medical University
Features of adherence to treatment of patients with chronic rhinosinusitis with nasal polyps
Journal: Russian Bulletin of Otorhinolaryngology. 2022;87(1): 81‑86
Views: 955
Downloaded: 65
To cite this article:
Kim IA, Nosulya EV, Ragimova DR. Features of adherence to treatment of patients with chronic rhinosinusitis with nasal polyps. Russian Bulletin of Otorhinolaryngology.
2022;87(1):81‑86. (In Russ.)
https://doi.org/10.17116/otorino20228701181
Chronic polypous rhinosinusitis (CPR) is characterized by refractory to drug therapy and a high potential for recurrence after surgical treatment. One of the important factors limiting the effectiveness of drug therapy of CPR, in particular intranasal glucocorticosteroids (inGCSs), is the insufficient level of adherence to treatment of patients with CPR.
Generalization of data on the significance and ways to increase adherence to treatment of patients with CPR.
Materials of scientific publications included in the Cochrane Library, Russian Science Citation Index, MEDLINE, PubMed information bases were used as a data source. The material was selected based on the following keywords: “chronic rhinosinusitis”, “nasal polyps”, “intranasal glucocorticosteroids”, “adherence to treatment”.
Despite the fact that inGCSs are one of the main pathogenetically justified methods of treating CPR, their use is limited by many factors, one of which is the level of patient compliance with the treatment regimen.
Improving adherence to treatment is one of the important reserves for increasing the effectiveness of drug therapy for chronic polypous rhinosinusitis.
Keywords:
Authors:
Kim I.A.
N.I. Pirogov Russian National Research Medical University;
National Medical Research Center of Otorhinolaryngology of Federal Medical-Biological Agency
Nosulya E.V.
Sverzhevky Research Clinical Institute of Otorhinolaryngology
Ragimova D.R.
Pirogov National Research Medical University
Received:
27.10.2021
Accepted:
24.12.2021
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.